Certain Network Devices, Related Software and Components Thereof (II); Commission Decision To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions, 12844-12847 [2017-04343]

Download as PDF 12844 Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices written submissions must conform with the provisions of section 201.8 of the Commission’s rules; any submissions that contain BPI must also conform with the requirements of sections 201.6, 207.3, and 207.7 of the Commission’s rules. The Commission’s Handbook on E-Filing, available on the Commission’s Web site at https://www.usitc.gov/ secretary/documents/handbook_on_ filing_procedures.pdf, elaborates upon the Commission’s rules with respect to electronic filing. Additional written submissions to the Commission, including requests pursuant to section 201.12 of the Commission’s rules, shall not be accepted unless good cause is shown for accepting such submissions, or unless the submission is pursuant to a specific request by a Commissioner or Commission staff. In accordance with sections 201.16(c) and 207.3 of the Commission’s rules, each document filed by a party to the reviews must be served on all other parties to the reviews (as identified by either the public or BPI service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. The Commission has determined that these reviews are extraordinarily complicated and therefore has determined to exercise its authority to extend the review period by up to 90 days pursuant to 19 U.S.C.1675(c)(5)(B). Authority: These reviews are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.62 of the Commission’s rules. By order of the Commission. Issued: March 2, 2017. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2017–04372 Filed 3–6–17; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION sradovich on DSK3GMQ082PROD with NOTICES [Investigation No. 337–TA–945] Certain Network Devices, Related Software and Components Thereof (II); Commission Decision To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade SUMMARY: VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 Commission has determined to review in part the presiding administrative law judge’s (‘‘ALJ’’) final initial determination (‘‘Final ID’’) issued on December 9, 2016, finding a violation of section 337 of the Tariff Act of 1930, as amended, (‘‘section 337’’) in the abovecaptioned investigation. FOR FURTHER INFORMATION CONTACT: Megan M. Valentine, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 708–2301. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on January 27, 2015, based on a Complaint filed by Cisco Systems, Inc. of San Jose, California (‘‘Cisco’’). 80 FR 4313–14 (Jan. 27, 2015). The Complaint alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the sale for importation, importation, and sale within the United States after importation of certain network devices, related software and components thereof by reason of infringement of certain claims of U.S. Patent Nos. 7,023,853; 6,377,577; 7,460,492; 7,061,875; 7,224,668; and 8,051,211. The Complaint further alleges the existence of a domestic industry. The Commission’s Notice of Investigation named Arista Networks, Inc. of Santa Clara, California (‘‘Arista’’) as respondent. The Office of Unfair Import Investigations (‘‘OUII’’) was also named as a party to the investigation. The Commission previously terminated the investigation in part as to certain claims of the asserted patents. Order No. 38 (Oct. 27, 2015), unreviewed Notice (Nov. 18, 2015); Order No. 47 (Nov. 9, 2015), unreviewed Notice (Dec. 1, 2015). On December 9, 2016, the ALJ issued her Final ID, finding a violation of section 337 with respect to claims 1, 7, 9, 10, and 15 of the ’577 patent; and claims 1, 2, 4, 5, 7, 8, 10, 13, 18, 56, and PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 64 of the ’668 patent. The ALJ found no violation of section 337 with respect to claim 2 of the ’577 patent; claims 46 and 63 of the ’853 patent; claims 1, 3, and 4 of the ’492 patent; claims 1–4, and 10 of the ’875 patent; and claims 2, 6, 13, and 17 of the ’211 patent. In particular, the Final ID finds that Cisco has shown by a preponderance of the evidence that the accused products infringe asserted claims 1, 7, 9, 10, and 15 of the ’577 patent; and asserted claims 1, 2, 4, 5, 7, 8, 10, 13, 18, 56, and 64 of the ’668 patent. The Final ID finds that Cisco has failed to show by a preponderance of the evidence that the accused products infringe asserted claim 2 of the ’577 patent; asserted claims 46 and 63 of the ’853 patent; asserted claims 1, 3, and 4 of the ’492 patent; asserted claims 1–4, and 10 of the ’875 patent; and asserted claims 2, 6, 13, and 17 of the ’211 patent. The Final ID also finds that assignor estoppel bars Arista from asserting that the ’577 and ’853 patents are invalid. The Final ID finds, however, that if assignor estoppel did not apply, Arista has shown by clear and convincing evidence that claims 1, 7, 9, 10, and 15 of the ’577 patent and claim 46 of the ’853 patent are invalid as anticipated by U.S. Patent No. 5,920,886 (‘‘Feldmeier’’). The Final ID further finds that Arista has failed to show by clear and convincing evidence that any of the remaining asserted claims are invalid. The Final ID also finds that Arista has not proven by clear and convincing evidence that Cisco’s patent claims are barred by equitable estoppel, waiver, implied license, laches, unclean hands, or patent misuse. The Final ID finds that Cisco has satisfied the economic prong of the domestic industry requirement for all of the patents-in-suit pursuant to 19 U.S.C. 337(A), (B), and (C). The Final ID finds, however, that Cisco has failed to satisfy the technical prong of the domestic industry requirement with respect to the ’875, ’492, and ’211 patents. The Final ID finds that Cisco has satisfied the technical prong with respect to the ’577, ’853, and ’668 patents. The Final ID also contains the ALJ’s recommended determination on remedy and bonding. The ALJ recommended that the appropriate remedy is a limited exclusion order with a certification provision and a cease and desist order against Arista. The ALJ recommended the imposition of a bond of 5% during the period of Presidential review. On December 29, 2016, Cisco, Arista, and OUII each filed petitions for review of various aspects of the Final ID. As described below, some of the issues E:\FR\FM\07MRN1.SGM 07MRN1 sradovich on DSK3GMQ082PROD with NOTICES Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices presented for review were in the form of contingent petitions. Cisco petitions for review of the Final ID’s construction of certain limitations recited in claim 46 of the ’853 patent and the resulting finding that Arista’s accused products do not infringe that claim. Cisco also petitions for review of the Final ID’s findings of noninfringement and non-satisfaction of the technical prong of the domestic industry requirement with respect to the ’875, ’492, and ’211 patents. Cisco requests contingent review of the Final ID’s finding that Arista does not indirectly infringe the asserted claims of the ’577 patent should the Commission review the Final ID’s finding that Arista’s postimportation direct infringement cannot alone support a finding of violation of section 337. Cisco also requests contingent review of the Final ID’s finding that Feldmeier anticipates the asserted claims of the ’577 patent should the Commission review the Final ID’s finding that assignor estoppel applies. Arista petitions for review of the Final ID’s construction of certain limitations recited in the asserted claims of the ’577 and ’668 patents and the resulting finding that certain of Arista’s accused products infringe those claims. Arista also petitions for review of the Final ID’s findings of indirect infringement with respect to the ’577 and ’668 patents. Arista further petitions for review of the Final ID’s finding that assignor estoppel precludes Arista from challenging the validity of the ’577 and ’853 patents. Arista requests contingent review of the Final ID’s finding that claim 46 of the ’853 patent is invalid as anticipated and indefinite should the Commission review the ALJ’s noninfringement findings with respect to that claim. Arista also requests contingent review of the issue of indirect infringement regarding the ’853, ’211, ’875, and ’492 patents should the Commission review the Final ID’s findings of no direct infringement with respect to those patents. OUII petitions for review of the Final ID’s finding that the ‘‘configurable PiP CoPP’’ implementation in Arista’s accused products infringes the asserted claims of the ’668 patent. OUII also petitions for review of the Final ID’s reliance on the Patent Trial and Appeal Board decision in finding that claims 1 and 12 of the ’211 patent are invalid as anticipated. OUII requests contingent review of the Final ID’s finding that Feldmeier anticipates the asserted claims of the ’577 patent should the Commission review the Final ID’s finding that assignor estoppel applies. OUII further requests contingent review VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 of the Final ID’s construction of certain means-plus-functions claims recited in claim 46 of the ’853 patent should the Commission review the Final ID’s finding that the accused products do not infringe that claim. On January 10, 2017, Cisco, Arista, and OUII filed responses to the various petitions for review. On January 11, 2017, Cisco and Arista each filed a post-RD statement on the public interest pursuant to Commission Rule 210.50(a)(4). No responses were filed by the public in response to the post-RD Commission Notice issued on December 20, 2016. See Notice of Request for Statements on the Public Interest (Dec. 20, 2016); 81 FR 95194– 95 (Dec. 27, 2016). Having examined the record of this investigation, including the Final ID, the petitions for review, and the responses thereto, the Commission has determined to review the Final ID in part. With respect to the ’577 patent, the Commission has determined to review the Final ID’s finding that Arista has indirectly infringed the ’577 patent by importing Imported Components, as referenced at page 110 in the Final ID. The Commission has also determined to review the Final ID’s finding that Arista’s post-importation direct infringement cannot alone support a finding of violation of section 337. The Commission has further determined to review the Final ID’s finding that Feldmeier anticipates claims 1, 7, 9, 10, and 15 of the ’577 patent. With respect to the ’853 patent, the Commission has determined to review the Final ID’s claim construction findings with respect to claim elements (c), (d), and (f) of claim 46. The Commission has also determined to review the Final ID’s findings concerning direct and indirect infringement regarding the ’853 patent. The Commission has further determined to review the Final ID’s finding that assignor estoppel applies to validity challenges based on indefiniteness. The Commission has also determined to review the Final ID’s finding that Feldmeier does not anticipate claim 46. With respect to the ’875 and ’492 patents, the Commission has determined to review the Final ID’s finding of no direct infringement and the related finding of no indirect infringement. The Commission has also determined to review the Final ID’s finding that Cisco has failed to satisfy the technical prong of the domestic industry requirement with respect to the ’875 and ’492 patents. With respect to the ’668 patent, the Commission has determined to review the Final ID’s finding of direct PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 12845 infringement and the Final ID’s finding of indirect infringement, in particular as concerns Arista’s importation of Imported Components. With respect to the ’211 patent, the Commission has determined to review the Final ID’s finding that Cisco has failed to satisfy the technical prong with respect to claims 1 and 12 of the ’211 patent, including the Final ID’s finding that claims 1 and 12 are invalid. The Commission has determined not to review the remaining issues decided in the Final ID. The parties are requested to brief their positions on the issues under review with reference to the applicable law and the evidentiary record. In connection with its review, the Commission is particularly interested in responses to the following questions: 1. Discuss the relevant case law regarding the requirement, pursuant to 35 U.S.C. 271(c), that to be found liable for contributory infringement, the accused infringer must import into the United States or sell within the United State a device that constitutes a ‘‘material part of the invention.’’ In addition, please address whether the Imported Components satisfy this requirement with respect to the ’577, ’853, and ’668 patents. Please cite to and discuss any relevant evidence in the record. 2. Please address whether the Accused ACL Products infringe asserted claim 46 of the ’853 patent if the 35 U.S.C. 112, ¶ 6 (means-plus-function) limitation ‘‘means for matching matchable information, said matchable information being responsive to said packet label, with said set of access control patterns in parallel’’ is construed to require as the corresponding structure an access control memory, including one or more content-addressable memory units of the type shown in Figure 2 of the ’853 patent. 3. Please address whether the Accused ACL Products infringe asserted claim 46 of the ’853 patent if the 35 U.S.C. 112, ¶ 6 (means-plus-function) limitation ‘‘means for generating a set of matches in response thereto, each said match having priority information associated therewith’’ is construed to require as the corresponding structure an access control memory, including one or more content-addressable memory units of the type shown in Figure 2 of the ’853 patent. 4. Please address whether the Accused ACL Products with the Petra chip infringe asserted claim 46 of the ’853 patent, in particular with respect to the 35 U.S.C. 112, ¶ 6 (means-plusfunction) limitation ‘‘means for E:\FR\FM\07MRN1.SGM 07MRN1 sradovich on DSK3GMQ082PROD with NOTICES 12846 Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices selecting at least one of said matches in response to said priority information, and generating an access result in response to said at least one selected match.’’ 5. Regarding the 35 U.S.C. 112, ¶ 6 (means-plus-function) limitation ‘‘means for making a routing decision in response to said access result’’ recited in asserted claim 46 of the ’853 patent, please address whether any corresponding structure disclosed in the specification of the ’853 patent satisfies the claimed function, other than the structure recited in the Final ID’s claim construction or the structures previously proposed by the parties. 6. With reference to question five, please address whether the Accused ACL Products infringe claim 46 of the ’853 patent under the proper construction of the 35 U.S.C. 112, ¶ 6 (means-plus-function) limitation ‘‘means for making a routing decision in response to said access result.’’ 7. Please address whether the Accused Loop Guard Products and the DI Loop Guard Products practice the limitation ‘‘including a discarding state’’ recited in claims 1 and 10 of the ’875 patent and/or the limitation ‘‘including a discarding port state’’ recited in claim 1 of the ’492 patent under the ALJ’s claim construction of ‘‘discarding [port] state,’’ which requires ‘‘a port state in a spanning tree protocol or algorithm in which data frames are neither forwarded to nor received from the port.’’ Please cite to and discuss any relevant evidence in the record. 8. Please address whether the Accused Loop Guard Products and the DI Loop Guard Products practice the limitation ‘‘including . . . a listening state’’ recited in claims 1 and 10 of the ’875 patent and/or the limitation ‘‘including . . . a listening [port] state’’ recited in claim 1 of the ’492 patent. In particular, please discuss the disclosure in exhibit CX–0653 at pages 63, 66, and 67. In addition, please cite to and discuss any other relevant evidence in the record. 9. With respect to the ’668 patent, please address whether the Pip CoPP feature in the ’668 Accused Products is a physical port service. In particular, please address the significance of the ALJ’s finding on page 196 of the Final ID. In addition, please cite to and discuss any relevant evidence in the record. The parties have been invited to brief only these discrete issues, as enumerated above, with reference to the applicable law and evidentiary record. The parties are not to brief other issues on review, which are adequately presented in the parties’ existing filings. VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 In connection with the final disposition of this investigation, the Commission may (1) issue an order that could result in the exclusion of the subject articles from entry into the United States, and/or (2) issue one or more cease and desist orders that could result in the respondent(s) being required to cease and desist from engaging in unfair acts in the importation and sale of such articles. Accordingly, the Commission is interested in receiving written submissions that address the form of remedy, if any, that should be ordered. If a party seeks exclusion of an article from entry into the United States for purposes other than entry for consumption, the party should so indicate and provide information establishing that activities involving other types of entry either are adversely affecting it or likely to do so. For background, see Certain Devices for Connecting Computers via Telephone Lines, Inv. No. 337–TA–360, USITC Pub. No. 2843 (December 1994) (Commission Opinion). If the Commission contemplates some form of remedy, it must consider the effects of that remedy upon the public interest. The factors the Commission will consider include the effect that an exclusion order and/or cease and desist orders would have on (1) the public health and welfare, (2) competitive conditions in the U.S. economy, (3) U.S. production of articles that are like or directly competitive with those that are subject to investigation, and (4) U.S. consumers. The Commission is therefore interested in receiving written submissions that address the aforementioned public interest factors in the context of this investigation. If the Commission orders some form of remedy, the U.S. Trade Representative, as delegated by the President, has 60 days to approve or disapprove the Commission’s action. See Presidential Memorandum of July 21, 2005, 70 FR 43251 (July 26, 2005). During this period, the subject articles would be entitled to enter the United States under bond, in an amount determined by the Commission and prescribed by the Secretary of the Treasury. The Commission is therefore interested in receiving submissions concerning the amount of the bond that should be imposed if a remedy is ordered. Written Submissions: The parties to the investigation, including the Office of Unfair Import Investigations, are requested to file written submissions on the issues identified in this notice. Parties to the investigation, including the Office of Unfair Import PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 Investigations, interested government agencies, and any other interested parties are encouraged to file written submissions on the issues of remedy, the public interest, and bonding. Such submissions should address the recommended determination by the ALJ on remedy and bonding. Complainant and the Office of Unfair Import Investigations are also requested to submit proposed remedial orders for the Commission’s consideration. Complainant is further requested to state the dates that the patents expire, the HTSUS numbers under which the accused products are imported, and any known importers of the accused products. The written submissions and proposed remedial orders must be filed no later than close of business on March 15, 2017. Initial submissions are limited to 50 pages, not including any attachments or exhibits related to discussion of the public interest. Reply submissions must be filed no later than the close of business on March 24, 2017. Reply submissions are limited to 25 pages, not including any attachments or exhibits related to discussion of remedy, the public interest, and bonding. No further submissions on these issues will be permitted unless otherwise ordered by the Commission. Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to section 210.4(f) of the Commission’s Rules of Practice and Procedure (19 CFR 210.4(f)). Submissions should refer to the investigation number (‘‘Inv. No. 337–TA–945’’) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, https://www.usitc.gov/ documents/handbook_on_filing_ procedures.pdf). Persons with questions regarding filing should contact the Secretary (202–205–2000). Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: (i) By the E:\FR\FM\07MRN1.SGM 07MRN1 Federal Register / Vol. 82, No. 43 / Tuesday, March 7, 2017 / Notices Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel,1 solely for cybersecurity purposes. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: March 1, 2017. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2017–04343 Filed 3–6–17; 8:45 am] BILLING CODE 7020–02–P JUDICIAL CONFERENCE OF THE UNITED STATES Meeting of the Judicial Conference Advisory; Committee on Rules of Criminal Procedure Advisory Committee on Rules of Criminal Procedure, Judicial Conference of the United States. ACTION: Notice of open meeting. AGENCY: The Advisory Committee on Rules of Criminal Procedure will hold a meeting on April 28, 2017. The meeting will be open to public observation but not participation. An agenda and supporting materials will be posted at least 7 days in advance of the meeting at: http://www.uscourts.gov/rulespolicies/records-and-archives-rulescommittees/agenda-books. DATES: April 28, 2017 from 8:30 a.m.– 5:30 p.m. ADDRESSES: Thurgood Marshall Federal Judiciary Building, Mecham Conference Center, Administrative Office of the United States Courts, One Columbus Circle NE., Washington, DC 20544. FOR FURTHER INFORMATION CONTACT: Rebecca A. Womeldorf, Rules Committee Secretary, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: 1 All contract personnel will sign appropriate nondisclosure agreements. VerDate Sep<11>2014 16:01 Mar 06, 2017 Jkt 241001 Dated: February 27, 2017. Rebecca A. Womeldorf, Rules Committee Secretary. [FR Doc. 2017–04322 Filed 3–6–17; 8:45 am] BILLING CODE 2210–55–P JUDICIAL CONFERENCE OF THE UNITED STATES Meeting of the Judicial Conference Advisory; Committee on Rules of Civil Procedure Advisory Committee on Rules of Civil Procedure, Judicial Conference of the United States. ACTION: Notice of open meeting. AGENCY: The Advisory Committee on Rules of Civil Procedure will hold a meeting on April 25–26, 2017. The meeting will be open to public observation but not participation. An agenda and supporting materials will be posted at least 7 days in advance of the meeting at: http://www.uscourts.gov/ rules-policies/records-and-archivesrules-committees/agenda-books. DATES: April 25–9:00 a.m. to 5:00 p.m. April 26–9:00 a.m. to 12:00 p.m. ADDRESSES: Hotel Ella, 1900 Rio Grande, Austin, Texas 78705. FOR FURTHER INFORMATION CONTACT: Rebecca A. Womeldorf, Rules Committee Secretary, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. SUMMARY: Dated: February 28, 2017. Rebecca A. Womeldorf, Rules Committee Secretary. BILLING CODE 2210–55–P Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Pistoia Alliance, Inc. Notice is hereby given that, on February 3, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages Fmt 4703 Sfmt 4703 Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017–04362 Filed 3–6–17; 8:45 am] BILLING CODE 4410–11–P Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical CBRN Defense Consortium DEPARTMENT OF JUSTICE Frm 00066 under specified circumstances. Specifically, Odysseus Data Services Inc., Cambridge, MA; Mike Furness (individual member), Ely, Cambridgeshire, United Kingdom; and Copyright Clearance Center, Danvers, MA, have been added as parties to this venture. Also, Sanofi, Frankfurt, Germany; BioReference Laboratories, Elmwood Park, NJ; BioVariance GmbH, Munich, Germany; and UCB Pharma SA, Brussels, Belgium, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional written notifications disclosing all changes in membership. On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 15, 2009 (74 FR 34364). The last notification was filed with the Department on November 14, 2016. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on December 13, 2016 (81 FR 89992). DEPARTMENT OF JUSTICE [FR Doc. 2017–04320 Filed 3–6–17; 8:45 am] PO 00000 12847 Notice is hereby given that, on February 3, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Biologics Modular, Brownsburg, IN; DynPort Vaccine Company, LLC, a CSRA Company, E:\FR\FM\07MRN1.SGM 07MRN1

Agencies

[Federal Register Volume 82, Number 43 (Tuesday, March 7, 2017)]
[Notices]
[Pages 12844-12847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04343]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-945]


Certain Network Devices, Related Software and Components Thereof 
(II); Commission Decision To Review in Part a Final Initial 
Determination Finding a Violation of Section 337; Request for Written 
Submissions

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined to review in part the presiding 
administrative law judge's (``ALJ'') final initial determination 
(``Final ID'') issued on December 9, 2016, finding a violation of 
section 337 of the Tariff Act of 1930, as amended, (``section 337'') in 
the above-captioned investigation.

FOR FURTHER INFORMATION CONTACT: Megan M. Valentine, Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 708-2301. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server at https://www.usitc.gov. The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on January 27, 2015, based on a Complaint filed by Cisco Systems, Inc. 
of San Jose, California (``Cisco''). 80 FR 4313-14 (Jan. 27, 2015). The 
Complaint alleges violations of section 337 of the Tariff Act of 1930, 
as amended, 19 U.S.C. 1337, in the sale for importation, importation, 
and sale within the United States after importation of certain network 
devices, related software and components thereof by reason of 
infringement of certain claims of U.S. Patent Nos. 7,023,853; 
6,377,577; 7,460,492; 7,061,875; 7,224,668; and 8,051,211. The 
Complaint further alleges the existence of a domestic industry. The 
Commission's Notice of Investigation named Arista Networks, Inc. of 
Santa Clara, California (``Arista'') as respondent. The Office of 
Unfair Import Investigations (``OUII'') was also named as a party to 
the investigation. The Commission previously terminated the 
investigation in part as to certain claims of the asserted patents. 
Order No. 38 (Oct. 27, 2015), unreviewed Notice (Nov. 18, 2015); Order 
No. 47 (Nov. 9, 2015), unreviewed Notice (Dec. 1, 2015).
    On December 9, 2016, the ALJ issued her Final ID, finding a 
violation of section 337 with respect to claims 1, 7, 9, 10, and 15 of 
the '577 patent; and claims 1, 2, 4, 5, 7, 8, 10, 13, 18, 56, and 64 of 
the '668 patent. The ALJ found no violation of section 337 with respect 
to claim 2 of the '577 patent; claims 46 and 63 of the '853 patent; 
claims 1, 3, and 4 of the '492 patent; claims 1-4, and 10 of the '875 
patent; and claims 2, 6, 13, and 17 of the '211 patent.
    In particular, the Final ID finds that Cisco has shown by a 
preponderance of the evidence that the accused products infringe 
asserted claims 1, 7, 9, 10, and 15 of the '577 patent; and asserted 
claims 1, 2, 4, 5, 7, 8, 10, 13, 18, 56, and 64 of the '668 patent. The 
Final ID finds that Cisco has failed to show by a preponderance of the 
evidence that the accused products infringe asserted claim 2 of the 
'577 patent; asserted claims 46 and 63 of the '853 patent; asserted 
claims 1, 3, and 4 of the '492 patent; asserted claims 1-4, and 10 of 
the '875 patent; and asserted claims 2, 6, 13, and 17 of the '211 
patent.
    The Final ID also finds that assignor estoppel bars Arista from 
asserting that the '577 and '853 patents are invalid. The Final ID 
finds, however, that if assignor estoppel did not apply, Arista has 
shown by clear and convincing evidence that claims 1, 7, 9, 10, and 15 
of the '577 patent and claim 46 of the '853 patent are invalid as 
anticipated by U.S. Patent No. 5,920,886 (``Feldmeier''). The Final ID 
further finds that Arista has failed to show by clear and convincing 
evidence that any of the remaining asserted claims are invalid. The 
Final ID also finds that Arista has not proven by clear and convincing 
evidence that Cisco's patent claims are barred by equitable estoppel, 
waiver, implied license, laches, unclean hands, or patent misuse.
    The Final ID finds that Cisco has satisfied the economic prong of 
the domestic industry requirement for all of the patents-in-suit 
pursuant to 19 U.S.C. 337(A), (B), and (C). The Final ID finds, 
however, that Cisco has failed to satisfy the technical prong of the 
domestic industry requirement with respect to the '875, '492, and '211 
patents. The Final ID finds that Cisco has satisfied the technical 
prong with respect to the '577, '853, and '668 patents.
    The Final ID also contains the ALJ's recommended determination on 
remedy and bonding. The ALJ recommended that the appropriate remedy is 
a limited exclusion order with a certification provision and a cease 
and desist order against Arista. The ALJ recommended the imposition of 
a bond of 5% during the period of Presidential review.
    On December 29, 2016, Cisco, Arista, and OUII each filed petitions 
for review of various aspects of the Final ID. As described below, some 
of the issues

[[Page 12845]]

presented for review were in the form of contingent petitions.
    Cisco petitions for review of the Final ID's construction of 
certain limitations recited in claim 46 of the '853 patent and the 
resulting finding that Arista's accused products do not infringe that 
claim. Cisco also petitions for review of the Final ID's findings of 
non-infringement and non-satisfaction of the technical prong of the 
domestic industry requirement with respect to the '875, '492, and '211 
patents. Cisco requests contingent review of the Final ID's finding 
that Arista does not indirectly infringe the asserted claims of the 
'577 patent should the Commission review the Final ID's finding that 
Arista's post-importation direct infringement cannot alone support a 
finding of violation of section 337. Cisco also requests contingent 
review of the Final ID's finding that Feldmeier anticipates the 
asserted claims of the '577 patent should the Commission review the 
Final ID's finding that assignor estoppel applies.
    Arista petitions for review of the Final ID's construction of 
certain limitations recited in the asserted claims of the '577 and '668 
patents and the resulting finding that certain of Arista's accused 
products infringe those claims. Arista also petitions for review of the 
Final ID's findings of indirect infringement with respect to the '577 
and '668 patents. Arista further petitions for review of the Final ID's 
finding that assignor estoppel precludes Arista from challenging the 
validity of the '577 and '853 patents. Arista requests contingent 
review of the Final ID's finding that claim 46 of the '853 patent is 
invalid as anticipated and indefinite should the Commission review the 
ALJ's non-infringement findings with respect to that claim. Arista also 
requests contingent review of the issue of indirect infringement 
regarding the '853, '211, '875, and '492 patents should the Commission 
review the Final ID's findings of no direct infringement with respect 
to those patents.
    OUII petitions for review of the Final ID's finding that the 
``configurable PiP CoPP'' implementation in Arista's accused products 
infringes the asserted claims of the '668 patent. OUII also petitions 
for review of the Final ID's reliance on the Patent Trial and Appeal 
Board decision in finding that claims 1 and 12 of the '211 patent are 
invalid as anticipated. OUII requests contingent review of the Final 
ID's finding that Feldmeier anticipates the asserted claims of the '577 
patent should the Commission review the Final ID's finding that 
assignor estoppel applies. OUII further requests contingent review of 
the Final ID's construction of certain means-plus-functions claims 
recited in claim 46 of the '853 patent should the Commission review the 
Final ID's finding that the accused products do not infringe that 
claim.
    On January 10, 2017, Cisco, Arista, and OUII filed responses to the 
various petitions for review.
    On January 11, 2017, Cisco and Arista each filed a post-RD 
statement on the public interest pursuant to Commission Rule 
210.50(a)(4). No responses were filed by the public in response to the 
post-RD Commission Notice issued on December 20, 2016. See Notice of 
Request for Statements on the Public Interest (Dec. 20, 2016); 81 FR 
95194-95 (Dec. 27, 2016).
    Having examined the record of this investigation, including the 
Final ID, the petitions for review, and the responses thereto, the 
Commission has determined to review the Final ID in part.
    With respect to the '577 patent, the Commission has determined to 
review the Final ID's finding that Arista has indirectly infringed the 
'577 patent by importing Imported Components, as referenced at page 110 
in the Final ID. The Commission has also determined to review the Final 
ID's finding that Arista's post-importation direct infringement cannot 
alone support a finding of violation of section 337. The Commission has 
further determined to review the Final ID's finding that Feldmeier 
anticipates claims 1, 7, 9, 10, and 15 of the '577 patent.
    With respect to the '853 patent, the Commission has determined to 
review the Final ID's claim construction findings with respect to claim 
elements (c), (d), and (f) of claim 46. The Commission has also 
determined to review the Final ID's findings concerning direct and 
indirect infringement regarding the '853 patent. The Commission has 
further determined to review the Final ID's finding that assignor 
estoppel applies to validity challenges based on indefiniteness. The 
Commission has also determined to review the Final ID's finding that 
Feldmeier does not anticipate claim 46.
    With respect to the '875 and '492 patents, the Commission has 
determined to review the Final ID's finding of no direct infringement 
and the related finding of no indirect infringement. The Commission has 
also determined to review the Final ID's finding that Cisco has failed 
to satisfy the technical prong of the domestic industry requirement 
with respect to the '875 and '492 patents.
    With respect to the '668 patent, the Commission has determined to 
review the Final ID's finding of direct infringement and the Final ID's 
finding of indirect infringement, in particular as concerns Arista's 
importation of Imported Components.
    With respect to the '211 patent, the Commission has determined to 
review the Final ID's finding that Cisco has failed to satisfy the 
technical prong with respect to claims 1 and 12 of the '211 patent, 
including the Final ID's finding that claims 1 and 12 are invalid.
    The Commission has determined not to review the remaining issues 
decided in the Final ID.
    The parties are requested to brief their positions on the issues 
under review with reference to the applicable law and the evidentiary 
record. In connection with its review, the Commission is particularly 
interested in responses to the following questions:
    1. Discuss the relevant case law regarding the requirement, 
pursuant to 35 U.S.C. 271(c), that to be found liable for contributory 
infringement, the accused infringer must import into the United States 
or sell within the United State a device that constitutes a ``material 
part of the invention.'' In addition, please address whether the 
Imported Components satisfy this requirement with respect to the '577, 
'853, and '668 patents. Please cite to and discuss any relevant 
evidence in the record.
    2. Please address whether the Accused ACL Products infringe 
asserted claim 46 of the '853 patent if the 35 U.S.C. 112, ] 6 (means-
plus-function) limitation ``means for matching matchable information, 
said matchable information being responsive to said packet label, with 
said set of access control patterns in parallel'' is construed to 
require as the corresponding structure an access control memory, 
including one or more content-addressable memory units of the type 
shown in Figure 2 of the '853 patent.
    3. Please address whether the Accused ACL Products infringe 
asserted claim 46 of the '853 patent if the 35 U.S.C. 112, ] 6 (means-
plus-function) limitation ``means for generating a set of matches in 
response thereto, each said match having priority information 
associated therewith'' is construed to require as the corresponding 
structure an access control memory, including one or more content-
addressable memory units of the type shown in Figure 2 of the '853 
patent.
    4. Please address whether the Accused ACL Products with the Petra 
chip infringe asserted claim 46 of the '853 patent, in particular with 
respect to the 35 U.S.C. 112, ] 6 (means-plus-function) limitation 
``means for

[[Page 12846]]

selecting at least one of said matches in response to said priority 
information, and generating an access result in response to said at 
least one selected match.''
    5. Regarding the 35 U.S.C. 112, ] 6 (means-plus-function) 
limitation ``means for making a routing decision in response to said 
access result'' recited in asserted claim 46 of the '853 patent, please 
address whether any corresponding structure disclosed in the 
specification of the '853 patent satisfies the claimed function, other 
than the structure recited in the Final ID's claim construction or the 
structures previously proposed by the parties.
    6. With reference to question five, please address whether the 
Accused ACL Products infringe claim 46 of the '853 patent under the 
proper construction of the 35 U.S.C. 112, ] 6 (means-plus-function) 
limitation ``means for making a routing decision in response to said 
access result.''
    7. Please address whether the Accused Loop Guard Products and the 
DI Loop Guard Products practice the limitation ``including a discarding 
state'' recited in claims 1 and 10 of the '875 patent and/or the 
limitation ``including a discarding port state'' recited in claim 1 of 
the '492 patent under the ALJ's claim construction of ``discarding 
[port] state,'' which requires ``a port state in a spanning tree 
protocol or algorithm in which data frames are neither forwarded to nor 
received from the port.'' Please cite to and discuss any relevant 
evidence in the record.
    8. Please address whether the Accused Loop Guard Products and the 
DI Loop Guard Products practice the limitation ``including . . . a 
listening state'' recited in claims 1 and 10 of the '875 patent and/or 
the limitation ``including . . . a listening [port] state'' recited in 
claim 1 of the '492 patent. In particular, please discuss the 
disclosure in exhibit CX-0653 at pages 63, 66, and 67. In addition, 
please cite to and discuss any other relevant evidence in the record.
    9. With respect to the '668 patent, please address whether the Pip 
CoPP feature in the '668 Accused Products is a physical port service. 
In particular, please address the significance of the ALJ's finding on 
page 196 of the Final ID. In addition, please cite to and discuss any 
relevant evidence in the record.
    The parties have been invited to brief only these discrete issues, 
as enumerated above, with reference to the applicable law and 
evidentiary record. The parties are not to brief other issues on 
review, which are adequately presented in the parties' existing 
filings.
    In connection with the final disposition of this investigation, the 
Commission may (1) issue an order that could result in the exclusion of 
the subject articles from entry into the United States, and/or (2) 
issue one or more cease and desist orders that could result in the 
respondent(s) being required to cease and desist from engaging in 
unfair acts in the importation and sale of such articles. Accordingly, 
the Commission is interested in receiving written submissions that 
address the form of remedy, if any, that should be ordered. If a party 
seeks exclusion of an article from entry into the United States for 
purposes other than entry for consumption, the party should so indicate 
and provide information establishing that activities involving other 
types of entry either are adversely affecting it or likely to do so. 
For background, see Certain Devices for Connecting Computers via 
Telephone Lines, Inv. No. 337-TA-360, USITC Pub. No. 2843 (December 
1994) (Commission Opinion).
    If the Commission contemplates some form of remedy, it must 
consider the effects of that remedy upon the public interest. The 
factors the Commission will consider include the effect that an 
exclusion order and/or cease and desist orders would have on (1) the 
public health and welfare, (2) competitive conditions in the U.S. 
economy, (3) U.S. production of articles that are like or directly 
competitive with those that are subject to investigation, and (4) U.S. 
consumers. The Commission is therefore interested in receiving written 
submissions that address the aforementioned public interest factors in 
the context of this investigation.
    If the Commission orders some form of remedy, the U.S. Trade 
Representative, as delegated by the President, has 60 days to approve 
or disapprove the Commission's action. See Presidential Memorandum of 
July 21, 2005, 70 FR 43251 (July 26, 2005). During this period, the 
subject articles would be entitled to enter the United States under 
bond, in an amount determined by the Commission and prescribed by the 
Secretary of the Treasury. The Commission is therefore interested in 
receiving submissions concerning the amount of the bond that should be 
imposed if a remedy is ordered.
    Written Submissions: The parties to the investigation, including 
the Office of Unfair Import Investigations, are requested to file 
written submissions on the issues identified in this notice. Parties to 
the investigation, including the Office of Unfair Import 
Investigations, interested government agencies, and any other 
interested parties are encouraged to file written submissions on the 
issues of remedy, the public interest, and bonding. Such submissions 
should address the recommended determination by the ALJ on remedy and 
bonding. Complainant and the Office of Unfair Import Investigations are 
also requested to submit proposed remedial orders for the Commission's 
consideration. Complainant is further requested to state the dates that 
the patents expire, the HTSUS numbers under which the accused products 
are imported, and any known importers of the accused products. The 
written submissions and proposed remedial orders must be filed no later 
than close of business on March 15, 2017. Initial submissions are 
limited to 50 pages, not including any attachments or exhibits related 
to discussion of the public interest. Reply submissions must be filed 
no later than the close of business on March 24, 2017. Reply 
submissions are limited to 25 pages, not including any attachments or 
exhibits related to discussion of remedy, the public interest, and 
bonding. No further submissions on these issues will be permitted 
unless otherwise ordered by the Commission.
    Persons filing written submissions must file the original document 
electronically on or before the deadlines stated above and submit 8 
true paper copies to the Office of the Secretary by noon the next day 
pursuant to section 210.4(f) of the Commission's Rules of Practice and 
Procedure (19 CFR 210.4(f)). Submissions should refer to the 
investigation number (``Inv. No. 337-TA-945'') in a prominent place on 
the cover page and/or the first page. (See Handbook for Electronic 
Filing Procedures, https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf). Persons with questions regarding 
filing should contact the Secretary (202-205-2000).
    Any person desiring to submit a document to the Commission in 
confidence must request confidential treatment. All such requests 
should be directed to the Secretary to the Commission and must include 
a full statement of the reasons why the Commission should grant such 
treatment. See 19 CFR 201.6. Documents for which confidential treatment 
by the Commission is properly sought will be treated accordingly. All 
information, including confidential business information and documents 
for which confidential treatment is properly sought, submitted to the 
Commission for purposes of this Investigation may be disclosed to and 
used: (i) By the

[[Page 12847]]

Commission, its employees and Offices, and contract personnel (a) for 
developing or maintaining the records of this or a related proceeding, 
or (b) in internal investigations, audits, reviews, and evaluations 
relating to the programs, personnel, and operations of the Commission 
including under 5 U.S.C. Appendix 3; or (ii) by U.S. government 
employees and contract personnel,\1\ solely for cybersecurity purposes. 
All nonconfidential written submissions will be available for public 
inspection at the Office of the Secretary and on EDIS.
---------------------------------------------------------------------------

    \1\ All contract personnel will sign appropriate nondisclosure 
agreements.
---------------------------------------------------------------------------

    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.

    Issued: March 1, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017-04343 Filed 3-6-17; 8:45 am]
 BILLING CODE 7020-02-P